Lilach Weisz
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 10%
- Biotechnology top 5%
- Pathology and Forensic Medicine
- Co-authors
- Moshe OrenVarda RotterPerry StambolskyNaomi GoldfingerGiulia FontemaggiRevital Maor-AloniIgor ShatsGiovanni Blandino
- Topics
- Cancer-related Molecular Pathways (7 papers)Cell death mechanisms and regulation (3 papers)Cancer Research and Treatments (2 papers)
- Cited by
- OncologyCancer ResearchBiotechnology
In The Last Decade
Lilach Weisz
10 papers receiving 985 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 692
- Oncology 609
- Cancer Research 273
- Biotechnology 127
- Pathology and Forensic Medicine 107
Countries citing papers authored by Lilach Weisz
This map shows the geographic impact of Lilach Weisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Weisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Weisz more than expected).
Fields of papers citing papers by Lilach Weisz
This network shows the impact of papers produced by Lilach Weisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Weisz. The network helps show where Lilach Weisz may publish in the future.
Co-authorship network of co-authors of Lilach Weisz
This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Weisz. A scholar is included among the top collaborators of Lilach Weisz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Weisz. Lilach Weisz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 196 | |
| 2 | 7 | |
| 3 | 22 | |
| 4 | 170 | |
| 5 | 61 | |
| 6 | 165 | |
| 7 | 68 | |
| 8 | 169 | |
| 9 | 48 | |
| 10 | 105 |
About Lilach Weisz
Lilach Weisz is a scholar working on Oncology, Biotechnology and Hepatology, having authored 10 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Cell death mechanisms and regulation (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (609 citations), Cancer Research (273 citations) and Biotechnology (127 citations). Lilach Weisz has collaborated with scholars based in Israel, Australia and Greece. Frequent co-authors include Moshe Oren, Varda Rotter, Perry Stambolsky, Naomi Goldfinger, Giulia Fontemaggi, Revital Maor-Aloni, Igor Shats, Giovanni Blandino, Eyal Kalo and Amir Zalcenstein. Their work appears in journals such as Molecular and Cellular Biology, Cancer Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.